KOSPI Sinks to a Seven-Month Low as Foreign Selling Meets an Oil Spike

Seoul — October 26, 2026. Published after the market close; index and stock prices are official closing values, while the exchange rate is an indicative quote, as currencies trade continuously with no official close.

Daily investor flows in Korea
Daily net purchases by investor type (KOSPI + KOSDAQ combined).

The 30-second version

  • The KOSPI closed at 5,469.47, down 1.46% — its lowest finish since April 6, 2026, roughly seven months ago.
  • The KOSDAQ fell harder, down 3.26% to 727.21, a three-month low.
  • Foreign investors sold a net 705.6 billion won (about $530 million) of KOSPI shares. Institutions and retail bought the dip but could not stop the slide.
  • Surging oil prices on US-Iran military tension set the tone from the open, with the US Federal Reserve meeting looming later this week.
  • The one bright spot: medical-AI and robotics stocks surged, several up 28-35% on the day.
  • The won firmed slightly, with USD/KRW quoted around 1,322 late in the session.

Why the market fell: oil, Iran, and a wall of foreign selling

Three forces stacked on top of each other today. First, rising military tension between the United States and Iran sent international oil prices sharply higher, and the KOSPI slipped below the 5,500 line almost immediately after the open (Herald Business). Second, foreign investors kept selling throughout the session, which widened the losses as the day went on. Third, nobody wanted to take big positions ahead of the US Fed’s October policy meeting — the FOMC — later this week, so there was little appetite to buy the dip aggressively.

The flow numbers tell the story. On the KOSPI, foreigners dumped a net 705.6 billion won (roughly $530 million), while institutions absorbed 610.6 billion won (about $460 million) and retail investors added a modest 58 billion won (Newspim). On the KOSDAQ the pattern flipped: institutions led the selling at a net 131.6 billion won, while individuals bought 90.2 billion won and foreigners were small net buyers at 33.1 billion won. Most sectors closed lower — pharmaceuticals fell 1.73%, non-metals 1.44%, electronics 0.96%, and retail 0.69%.

The exception: medical AI and robotics ran hard

Against that red backdrop, one theme stood out dramatically: medical AI and robotics — what Korean markets call “physical AI,” meaning AI embodied in machines rather than living only in software. Big Wave Robotics jumped 35.28%, ICH 34.22%, Lunit 30.69%, Noul 29.94%, VUNO 28.43%, and Contec 28.04%, with a tail of smaller names up double digits.

The drivers were concrete rather than purely speculative. Robotics suppliers rallied on expectations of growing shipments of robot components such as actuators as global physical-AI demand expands. On the medical-AI side, Lunit got a boost from reports valuing its AI pathology and biomarker business at a minimum of 500 billion won (around $380 million) plus hopes for its US expansion, including participation in the CancerX initiative. Noul rose on a planned third-party share placement and an expected change of its largest shareholder (Money Today).

A few heavyweights also finished green: SK hynix gained 1.19% on semiconductor strength, Samsung Life rose 3.29%, Samsung C&T 1.57%, SK Square 0.92%, and Samsung Electro-Mechanics 0.63%, helped by bargain hunting.

Banks led the big-cap decline; speculative small caps unwound

Banks were the most conspicuous large-cap losers: KB Financial dropped 3.79% to 147,200 won and Shinhan Financial fell 2.84% to 85,500 won. Notably, local media could not identify a specific disclosure or piece of bad news behind the move — beyond recent stake and treasury-share chatter, the trigger remains unclear. Elsewhere among large caps, Hyundai Motor lost 2.05%, LG Energy Solution 1.97%, Celltrion 1.66%, Kia 1.50%, and Samsung Biologics 0.89%, while Samsung Electronics edged down 0.23% to 213,000 won.

On the KOSDAQ, the carnage was concentrated in small caps and thinly traded preferred shares — a class of stock that often swings wildly in Korea because so few shares change hands. Softcen preferred crashed 55.35% and CJ Seafood first preferred 53.10%, with names like Speco, Hydro Lithium, and L&C Bio down 17-22%, mostly profit-taking after earlier sharp run-ups.

Key closing numbers

Item Close Change Note
KOSPI 5,469.47 -1.46% (-80.83 pts) Lowest since April 6, 2026
KOSDAQ 727.21 -3.26% (-24.48 pts) Lowest since July 31, 2026
USD/KRW (indicative quote) around 1,322 Won slightly stronger Continuously traded; no official close
KOSPI foreign net flow -705.6bn won ~-$530M Led the selling
KOSPI institutional net flow +610.6bn won ~+$460M Absorbed the supply
KOSDAQ institutional net flow -131.6bn won ~-$100M Led KOSDAQ selling

What to watch next

  • The US FOMC decision late this week. CME FedWatch puts the probability of an October rate hold at 90.59%, so the market reaction will hinge on the Fed’s forward guidance more than the decision itself.
  • Whether foreign selling of KOSPI shares continues — it has been the dominant pressure on the index.
  • US-Iran headlines and oil prices, today’s initial trigger.
  • Kiwoom Securities sees the KOSPI trading in a 5,300-5,800 band this week, with elevated intraday volatility around the event cluster of the FOMC and major earnings.
  • Whether the medical-AI and robotics rally holds, or unwinds the way today’s crashed small caps did after their own run-ups.

FAQ

Why did the KOSPI fall on October 26, 2026?
Three reasons combined: oil prices spiked on rising US-Iran military tension, foreign investors sold a net 705.6 billion won (about $530 million) of KOSPI shares, and traders turned cautious ahead of the US Fed’s FOMC meeting later in the week. The index closed at 5,469.47, its lowest in about seven months.

Who was selling Korean stocks today?
On the KOSPI, foreign investors drove the decline, while institutions and retail investors were net buyers. On the KOSDAQ the roles reversed: institutions were the main sellers, and individuals and foreigners bought on balance.

Why did Lunit and other medical-AI stocks surge?
Lunit jumped 30.69% after its AI pathology and biomarker business was reportedly valued at a minimum of 500 billion won, alongside US expansion hopes including the CancerX initiative. Peers like VUNO and Noul rallied in sympathy on broader expectations that Korean medical-AI firms will expand overseas, while robotics names rose on physical-AI component demand.

Is the Korean won getting stronger?
Slightly, yes. USD/KRW was quoted around 1,322, slightly lower on the day, and the rate has been hovering in the low-1,320s — near its lowest levels of the year, which means the won is near its strongest levels of 2026 against the dollar.


Disclaimer: This is an information and analysis publication, not investment advice. See our Methodology for data sources, standards, and our corrections policy.


Also on Seoul Closing Bell

A companion piece on the same session, written from a different angle: Foreign Investors Dumped KOSPI, Yet the Won Got Stronger.


Related reading